Open Trial of Escitalopram Treatment for Male Subjects With Posttraumatic Stress Disorder
Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
The primary aim of this pilot study is to test the efficacy of the selective serotonin
re-uptake inhibitor, Escitalopram, in the treatment of posttraumatic stress disorder (PTSD)
in an open clinical trial.
A secondary aim is to determine whether treatment with escitalopram increases plasma
allopregnanolone levels in patients with PTSD and if increases in allopregnanolone levels are
correlated with treatment efficacy.
Phase:
N/A
Details
Lead Sponsor:
Northern California Institute of Research and Education